Status:
UNKNOWN
SERUM VITAMIN B12 LEVELS IN PATIENTS WITH HEMORRHAGIC VS ISCHEMIC CEREBROVASCULAR EVENT.
Lead Sponsor:
Hospital General de Mexicali
Collaborating Sponsors:
Sandoval Briones Jocelin Lisset
Hirata Medina Nancy Midory
Conditions:
Cerebrovascular Event
Vitamin b12
Eligibility:
All Genders
18+ years
Brief Summary
Cerebral vascular events (CVA) have a high prevalence in our environment; they are the first cause of disability and the second cause of death in the world (6.6 million deaths). 71% of all strokes wor...
Detailed Description
General objective: To demonstrate if there is a difference between serum levels of vitamin B12 in patients with hemorrhagic cerebral vascular event compared to patients with ischemic cerebral vascular...
Eligibility Criteria
Inclusion
- Age over 18 years
- Have a diagnosis of a cerebral vascular event
- Being a hospitalized patient at the General Hospital of Mexicali
Exclusion
- Patients without lab tests during their hospitalization
- Patients without a cranial CT scan
Key Trial Info
Start Date :
November 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06190314
Start Date
November 13 2023
End Date
November 30 2024
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Mexicali
Mexicali, Estado de Baja California, Mexico, 21000